KHTRF News Alert Knight Therapeutics (KHTRF) 5.9595 12/26/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Knight Therapeutics (KHTRF) 5.9595 $KHTRF

Knight Further Executes Its Innovative Pharmaceutical Product Sourcing Strategy
Marketwired - Tue Dec 16, 7:04AM CST
Knight Therapeutics Inc. (TSX: GUD), through one of its wholly owned subsidiaries ("Knight" , announced today that it has committed to invest US$25 million into Domain Partners IX, L.P. ("Domain Fund" and US$10 million in Sanderling Ventures VII, L.P. ("Sanderling Fund" . These investments into proven successful life science funds complement Knight Therapeutics Inc.'s US$13 million investment in Sectoral, EUREUR19.5 million investment in Forbion, and CAD$30 million investment in Teralys. These five funds have combined assets under management in healthcare of approximately CAD$9 billion.
GUD.TO: 6.92 (+0.02)

IIROC Trade Resumption - Knight Therapeutics Inc.
Newsfile Corp - Thu Dec 04, 7:45AM CST
Trading resumes in:

IIROC Trade Halt - Knight Therapeutics Inc.
Newsfile Corp - Wed Dec 03, 3:10PM CST
The following issues have been halted by IIROC:

Knight Therapeutics Inc. and CRH Medical Corporation Sign Secured Debt Financing Agreement
Marketwired - Tue Dec 02, 9:15AM CST
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into a senior secured debt agreement with CRH Medical Corporation (TSX: CRH)(OTCQX: CRMMF) ("CRH" , a North American medical company focused on providing physicians with innovative products and services for the treatment of gastrointestinal diseases. This secured loan will fund CRH's acquisition of Gastroenterology Anesthesia Associates, LLC and GAA Management, LCC, collectively a Southeast US-based Anesthesia services provider ("GAA" .
CRH.TO: 1.70 (+0.01), GUD.TO: 6.92 (+0.02)

Humanitarian groups take issue with Knight Therapeutics' PRV windfall
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 8:22AM CST

GILD: 91.29 (+1.84)

Knight Sells Priority Review Voucher to Gilead
Marketwired - Wed Nov 19, 4:11PM CST
Knight Therapeutics Inc., (TSX: GUD) through one of its wholly owned subsidiaries ("Knight" , today announced the sale of its Neglected Tropical Disease Priority Review Voucher ("PRV" . The PRV was granted to Knight in March of this year with the approval of Impavido(R) (miltefosine) for treatment of patients with visceral, mucosal and cutaneous leishmaniasis. Upon closing of the transaction, Knight will receive US$125 million in cash from Gilead Sciences, Inc. in exchange for the PRV. Knight was advised in the transaction by global investment banking firm, Jefferies LLC.
GILD: 91.29 (+1.84), GUD.TO: 6.92 (+0.02)

Knight Reports Third Quarter 2014 Results
Marketwired - Wed Nov 12, 5:02AM CST
Knight Therapeutics Inc. ("Knight" (TSX: GUD) today reported its financial results for the quarter ended September 30, 2014.
GUD.TO: 6.92 (+0.02)

Notice of Knight Therapeutics' Third Quarter 2014 Results Conference Call
Marketwired - Thu Nov 06, 7:07AM CST
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, will release its third quarter 2014 financial results on Wednesday, November 12, 2014 prior to the market opening. Following the release, Knight will hold a conference call at 8:30 a.m. (EST) hosted by Jonathan Goodman, President and CEO of Knight. Knight cordially invites all interested parties to participate in this call.
GUD.TO: 6.92 (+0.02)

Knight Therapeutics Inc. Continues to Execute Its Innovative Pharmaceutical Product Sourcing Strategy
Marketwired - Tue Oct 28, 7:09AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has invested CAD$30 million into Teralys Capital Innovation Fund LP ("Teralys Fund" . This investment in another proven successful life science fund complements Knight's USD$13 million investment in Sectoral and EUR19.5 million investment in Forbion.
GUD.TO: 6.92 (+0.02)

Knight Therapeutics Inc. Expands Its Innovative Pharmaceutical Product Sourcing Strategy
Marketwire - Thu Oct 02, 7:31AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has expanded its innovative pharmaceutical product sourcing strategy for the Canadian market. This strategy is based on the conviction that with targeted incentives, an investment in time proven life science funds will generate preferential access globally to top biotechnology and pharmaceutical companies and their products.
GUD.TO: 6.92 (+0.02)

Knight Therapeutics Inc. Acquires Orphan Canada Inc. and Expands Business Development Capacity
Marketwire - Tue Sep 02, 7:33AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" , a leading Canadian specialty pharmaceutical company, announced today that it has entered into an asset purchase agreement with Orphan Canada Inc. ("Orphan" related to the Canadian rights for ATryn(R) and PHOTOFRIN(R) (porfimer sodium), two innovative pharmaceutical products approved for sale in multiple jurisdictions. Orphan is a privately-held, Toronto-based specialty pharmaceutical company that in-licenses therapies for rare disorders and specialty medicines for the Canadian market.
GUD.TO: 6.92 (+0.02)

Knight Expands Team
Marketwire - Tue Aug 26, 7:04AM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" announced today (1) the appointment of Amal Khouri to the position of Vice President of Business Development and (2) the appointment of Sylvie Tendler to Knight's Board of Directors. "Both Amal and Sylvie are proven pharmaceutical executives and expand our capacity to secure the rights to innovative pharmaceuticals that improve the health of Canadians", said Jonathan Ross Goodman, President and CEO of Knight.
GUD.TO: 6.92 (+0.02)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 72

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
PPL's January Dividend Keeps Utility Appeal Intact

Updated Category News Views 85

A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...

Continue Reading
Straub's Court Win Raises Cost of Seven-Year Fight

Updated Category News Views 51

Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...

Continue Reading
Milwaukee County Contract Tests Wisconsin Labor Shift

Updated Category News Views 6

A unanimous first contract in a Milwaukee County department is not the sort of headline that rattles a trading screen, but it can tell you plenty about where the ground is moving. Public safety workers in the county Facilities Department have ratified their first agreement with Teamsters Local 344, according to the union. The vote matters less for any disclosed economic...

Continue Reading
Frost & Sullivan’s 65 Years Put APAC Growth on Display

Updated Category News Views 95

A Crowded Singapore Room Says Something Singapore did not host a mere anniversary toast on November 18; it hosted a pretty revealing cross-section of the businesses trying to build, secure, cool, connect, finance, and digitize Asia Pacific and MEASA. Frost & Sullivan marked 65 years with its 2026 Best Practices Recognition banquet at Hilton Singapore Orchard, gathering...

Continue Reading
Great Rail Journeys Bets Bigger on Luxury Rail in 2027

Updated Category News Views 99

A $19,995 vacation is not selling a seat on a train; it is selling relief from planning, crowds and compromise. Great Rail Journeys is leaning hard into that proposition for 2027 with two additions to its premium Landmark Collection: a Europe-heavy Orient Express and Rhône cruise pairing, plus a South Africa itinerary built around safari, Victoria Falls and rail-flavored...

Continue Reading
Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 13

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading
Art Limitless Jury Puts SDG 12 and Art Into Clear Focus

Updated Category News Views 56

A paint pigment, a discarded object, and a serious climate question have landed in the same room. BE OPEN Art’s 2026 Art Limitless competition is aimed at SDG 12, the United Nations goal centered on responsible production and consumption. That may sound like institutional language built for conference folders, but the underlying issue is plain enough: society cannot...

Continue Reading
Boston Scientific Loads Debt Cannon for Penumbra Deal

Updated Category News Views 128

A Very Large Financing Cart Rolled Out Boston Scientific just put an enormous stack of paper into the market, and nobody should mistake this for routine housekeeping. The company priced $3.0 billion of U.S. dollar senior notes and €4.25 billion of euro notes, with proceeds earmarked chiefly for the cash portion of its proposed Penumbra acquisition, alongside cash on...

Continue Reading
S&P Global's December 8 Talk Puts Guidance in Focus

Updated Category News Views 0

A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Recent Options Trades in Goldman Sachs Group (GS)

Updated Category News Views 230

Bearish Sentiments in Goldman Sachs Group Options Recent activity in the financial market has brought to light the bearish stance among significant investors regarding Goldman Sachs Group (NYSE: GS). While it’s important for retail traders to stay informed, this trend signifies that something noteworthy may be unfolding within the company. Insights from Options...

Continue Reading
Calamos Investments Launches Innovative Bitcoin ETFs with Protection

Updated Category News Views 310

Calamos Investments Introduces Unique Bitcoin ETFs Offering Significant Protection Calamos Investments has recently made headlines with the launch of two groundbreaking exchange-traded funds (ETFs), designed to provide investors with innovative exposure to Bitcoin while maintaining notable downside protection. These new ETFs, namely the CBXJ and CBTJ, offer 90% and 80%...

Continue Reading
Mawson Infrastructure Group Reports Impressive Q3 Financial Gains

Updated Category News Views 192

Mawson Infrastructure Group's Notable Q3 Performance Mawson Infrastructure Group Inc. (NASDAQ: MIGI) is a technology company focused on establishing and managing advanced digital infrastructure platforms. The company recently revealed its financial and operational results, marking the conclusion of the third quarter and the year-to-date for 2025. Financial Highlights from...

Continue Reading
Nékter Juice Bar Teams Up with Krista Horton for New Smoothie

Updated Category News Views 3272

Nékter Juice Bar Launches Exciting Smoothie Collaboration The Krista Kolada Combines Clean Ingredients with Social Power Nékter Juice Bar, a leading name in providing fresh and healthy juice options, has recently rolled out a delightful new offering for its fans. The introduction of the Krista Kolada smoothie marks an exciting collaboration with lifestyle and parenting...

Continue Reading
Kintara Therapeutics Sets Record Date for Exciting CVR Issuance

Updated Category News Views 188

Kintara Therapeutics Announces Record Date for CVR Issuance Kintara Therapeutics, Inc. (NASDAQ: KTRA), a biopharmaceutical company dedicated to developing innovative therapies for solid tumors, recently revealed a record date for the issuance of Contingent Value Rights (CVRs). These rights will be granted to stockholders of Kintara as part of its forthcoming merger with...

Continue Reading